<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000340925"><TermName>BG00001</TermName><TermDefinition><DefinitionText>A gene therapy agent that is being studied in the treatment of cancer. It belongs to the family of drugs called biological response modifiers.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>BG00001</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento de terapia genética que está en estudio para el tratamiento de cáncer. Es un tipo de modificador de la respuesta biológica.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-10-25</DateFirstPublished></GlossaryTerm>
